We chose SGLT-2 inhibitors as the secondary comparator because they are also used at a disease stage similar to GLP-1 receptor agonists and have not been associated with the outcome.16 For both cohorts, we defined cohort entry as the date of the first prescription for either a GLP-1 receptor agonist or the comparator drug during the study period
doi: 10.1016/j.exer.2019.107807 294 MastroMonacoCBalazsiMCoblentzJDiasABTZoroquiainPBurnierMN
In recent years, studies on the use of GLP-1R and GLP-1R agonists to reduce tau protein hyperphosphorylation have progressed
If you experience any new or worsening mental health symptoms, physical changes, or side effects that concern you, contact your healthcare provider right away
Though rare, some people have reported severe allergic reactions (including anaphylaxis) with both tirzepatide and semaglutide
Repurposing semaglutide and liraglutide for alcohol use disorder